论文部分内容阅读
目的比较介入治疗及甲氨蝶呤全身化疗对剖宫产术后瘢痕妊娠的治疗效果。方法将58例诊断为瘢痕妊娠的患者分为介入组和化疗组,栓塞组行双侧子宫动脉栓塞术+B超引导下清宫术。化疗组肌肉注射甲氨蝶呤注射液+B超引导下清宫术。观察2组患者术后血HCG恢复阴性时间、平均住院时间、术中出血量、病灶消失时间,月经恢复时间,治疗费用等,并进行比较。结果两组患者治疗后血HCG恢复阴性时间、平均住院时间、术中出血量、病灶消失时间及治疗费用的比较,差异均有统计学意义(P<0.05);两组患者治疗后月经恢复时间比较差异无统计学意义(P>0.05)。结论介入治疗及甲氨蝶呤化疗对瘢痕妊娠的治疗均有效,但介入治疗比甲氨蝶呤全身化疗更安全,风险低,较彻底,但治疗费用昂贵。
Objective To compare the therapeutic effects of interventional therapy and methotrexate systemic chemotherapy on scar pregnancy after cesarean section. Methods Fifty-eight patients diagnosed as scar pregnancy were divided into intervention group and chemotherapy group. The embolization group underwent bilateral uterine artery embolization with B-guided ultrasonography. Chemotherapy group intramuscular methotrexate injection + B-guided ultra-curettage. The postoperative blood HCG recovery time, average length of hospital stay, intraoperative blood loss, time to disappearance of lesions, recovery time of menstruation and treatment cost were observed and compared between two groups. Results After treatment, the blood HCG recovery negative time, average length of hospital stay, intraoperative blood loss, time to disappearance of lesions and treatment costs were significantly different between the two groups (P <0.05). After the treatment, the recovery period of menstruation The difference was not statistically significant (P> 0.05). Conclusion Both interventional therapy and methotrexate chemotherapy are effective in the treatment of scar pregnancy. However, interventional chemotherapy is safer, lower risk and more complete than methotrexate systemic chemotherapy, but the cost is high.